Brought to you by 
NxStage nets $51.4mm with FOPO
29 Jun 2006
Executive Summary
NxStage Medical (portable dialysis machine for patients with end-stage renal disease or acute kidney failure) has netted $51.4mm with the follow-on public offering of 6.3mm common shares (including the overallotment) priced at $8.75 each. Selling shareholders also placed 113k common shares as part of the transaction.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NxStage nets $51.4mm with FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice